HeartSciences (HSCS) vs CollPlant Biotechnologies (OPHI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
HeartSciences is the larger company by market cap ($10.4 million vs $9.6 million), about 1.1 times the size, while CollPlant Biotechnologies is growing revenue faster (+360.4% vs -0.7%). CollPlant Biotechnologies converts more of its revenue into profit, with a net margin of -484.6% versus -211666.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSCS | OPHI |
|---|---|---|
| Share price | $1.81 | $3.13 |
| Market cap | $10.42M | $9.63M |
| 1-day change | -10.84% | -2.49% |
| YTD return | -41.42% | — |
| 1-year return | -23.31% | — |
| EPS (TTM) | $-3.21 | $-9.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.32K | $2.37M |
| Revenue growth (YoY) | -0.71% | +360.39% |
| Net income (latest FY) | $-9.14M | $-11.49M |
| Gross margin | 59.06% | 64.78% |
| Operating margin | -194787.38% | -484.31% |
| Net margin | -211666.47% | -484.56% |
| 52-week high | $5.25 | $22.50 |
| 52-week low | $1.63 | $2.64 |
| Distance from 52-week high | -65.52% | -86.09% |
| Analyst consensus | buy | — |
| Avg. price target upside | +562.98% | — |
| Average volume | 162.54K | 385.37K |
| Shares outstanding | 5.76M | 3.08M |
| Employees | 14 | — |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CollPlant Biotechnologies is more profitable, keeping -484.6 cents of every revenue dollar as net income versus -211666.5 cents for HeartSciences.
- CollPlant Biotechnologies grew revenue faster in its latest fiscal year (+360.39% vs -0.71%).
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Health Care · Industrial Specialties · 14 employees
HSCS vs OPHI FAQ
Which is bigger, HeartSciences or CollPlant Biotechnologies?
HeartSciences (HSCS) is larger, with a market capitalization of $10.42M compared with $9.63M for CollPlant Biotechnologies (OPHI).
Are HeartSciences and CollPlant Biotechnologies in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.